#MSchat

Gregory MSgregory_ms
2026-01-31

gregory-ms.com/articles/311337

P400 and P625 were found to be effective in the experimental autoimmune encephalomyelitis (EAE), the principal animal model of MS.

Gregory MSgregory_ms
2026-01-30

Clinical trial: Digitally Supported Intervention to Master Complex Fall Risk Situations in Persons With Multiple Sclerosis - a Multicenter Study (STAR)

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-29

Clinical trial: Feasibility, Preliminary Efficacy, and User Perspective Usability of Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-29

Clinical trial: Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-28

Clinical trial: INFLUENCE OF THERAPEUTIC FAILURE ON THE PSYCHOSOCIAL EXPERIENCE OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-28

Clinical trial: Optimal Cut-off Points of Respiratory Muscle Strength and Endurance to Discriminate Disability Status in Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-27

Clinical trial: The Relationship Between Trunk Stability, Balance, Mobility, Upper Limb Performance, and Fatigue in Minimally to Moderately Disabled People With Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-27

Clinical trial: A Phase 1b, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics of Sapu003 in Advanced mTOR-sensitive Solid Tumors (With or Without Exemestane)

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-27

Clinical trial: Efficacy, safety and cost-effectiveness of B cell tailored ocrelizumab versus standard ocrelizumab in relapsing remitting multiple sclerosis (BLOOMS):
a randomized controlled trial

euclinicaltrials.eu/search-for

Gregory MSgregory_ms
2026-01-26

Clinical trial: The Effect of Different Dual-Task Conditions on Chewing Function in Individuals With Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-26

Clinical trial: A Phase IV, Prospective, Multicenter, Open-label, Mother-milk Study to Evaluate Ofatumumab Concentration in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis Receiving Ofatumumab

clinicaltrials.gov/study/NCT06

Gregory MSgregory_ms
2026-01-25

Clinical trial: A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: Probiotics as a Promising Adjunct: Improving Fatigue, Quality of Life, Disability, Mood and Inflammatory Markers in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-blind, Controlled Study

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: Effects of Therapeutic Exercise and Long-term Docosahexaenoic Acid (DHA) Supplementation on Physical, Physiological, Motor, Mental, and Cognitive Variables in Patients With Multiple Sclerosis.

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: EXpain - Is Exercise an Effective Non-pharmacological Analgesic Treatment in People With Multiple Sclerosis?

clinicaltrials.gov/study/NCT07

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst